Literature DB >> 21056388

[Pudendal nerve surgery in the management of chronic pelvic and perineal pain].

R Robert1, J-J Labat, M Khalfallah, J-M Louppe, T Riant, O Hamel.   

Abstract

OBJECTIVE: To define the place of pudendal nerve surgery in pudendal nerve entrapment syndromes.
MATERIALS AND METHODS: Description of the various surgical techniques and published results.
RESULTS: The original surgical technique, which remains the reference technique, consists of performing surgical release of the pudendal nerve from the infrapiriformis foramen to Alcock's canal via a transgluteal approach. This surgical procedure is safe and gives encouraging results validated by a prospective, randomized protocol: 66 to 80% of patients are improved. Other transvaginal or transperineal approaches have also been proposed.
CONCLUSION: Pudendal nerve surgery is a reasonable treatment option when all other treatments have failed. However, the various techniques proposed and their respective criticisms must be carefully evaluated.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21056388     DOI: 10.1016/j.purol.2010.09.016

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  3 in total

1.  [Not Available].

Authors:  Imad Ziouziou; Hassan Bennani; Mohamed Zizi; Tarik Karmouni; Khalid El Khader; Abdellatif Koutani; Ahmed Iben Attya Andaloussi
Journal:  Can Urol Assoc J       Date:  2013-07       Impact factor: 1.862

2.  [Pudendal neuralgia: Report on three cases].

Authors:  Imad Ziouziou; Yassine Rhannam; Souhail Yacoubi; Tariq Karmouni; Khalid El Khader; Abdellatif Koutani; Ahmed Iben Attya Andaloussi; Anass Nouri; Philippe Barre; Mohamed Nouri
Journal:  Can Urol Assoc J       Date:  2013 Mar-Apr       Impact factor: 1.862

3.  Turn-amplitude analysis as a diagnostic test for myofascial syndrome in patients with chronic pelvic pain.

Authors:  Fernando Itza; Daniel Zarza; Jesús Salinas; Fernando Teba; Carmen Ximenez
Journal:  Pain Res Manag       Date:  2015 Mar-Apr       Impact factor: 3.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.